Angiogenesis is a tightly controlled process which depends on the balance between stimulating and inhibiting factors. When this balance is disrupted, angiogenesis acquires a pathological meaning. The list of molecules able to induce angiogenesis is heterogeneous with respect to their chemical characteristics and biological properties. Quantitative measurement of tumor angiogenesis is necessary for the choice of therapeutic strategies and as an endpoint for antiangiogenic therapy. We are developing a quantitative RT-PCR which measures the expression of specific factors in real time. With the use of this rapid technique, measurement of the expression of the angiogenic factors and inhibitors is also possible in specimens as small as biopsies.
FolkmanJ.Angiogenesis in cancer, vascular rheumatoid and other disease.Nat Med1995; 1: 27–31.
4.
WeidnerN., FolkmanJ., PozzaF.Tumor angiogenesis: a new significant and independent prognostic indicator in early stage breast carcinoma.J Natl Canc Inst1992; 84: 1875–87.
5.
GalloO., MasiniE., MorbidelliL.Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer.J Natl Cancer Inst1998; 90: 587–95.
6.
GaspariniG., WeidnerN., MalutaS.Intratumoral microvessel density and p53 protein: correlation with metastasis in head and neck squamous-cell carcinoma.Int J Cancer1993; 55: 739–44.
7.
AlboD., GranikM.S., JhalaN.The relationship of angiogenesis to biological activity in human squamous cell carcinomas of the head and neck.Ann Plast Surg1994; 32: 588–92.
8.
KlijanienkoJ., el-NaggarA.K., de BraudF.Tumor vascularization, mitotic index, histopathologic grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas.Cancer1995; 75: 1649–56.
AndersonI.C., ShippM.A., DochertyA.J.P., TeicherB.A.Combination therapy including a gelatinase inhibitor and cytotoxic agent reduces local invasion and metastasis of murine Lewis lung carcinoma.Cancer Res1996; 56: 715–8.
11.
GiavazziR.Personal communication.
12.
ThomasH., AdamsM.A phase I clinical trial of the matrix metalloproteinase inhibitor marimastat administered concurrently with carboplatin to patients with relapsed ovarian cancer (abstract).Eur J Cancer1997; 33: S246
13.
FerraraN.Personal communication.
14.
ZicheM., MorbildelliL., AlessandriG., GullinoP.M.Angiogenesis can be stimulated or repressed in vivo by a change in the GM3: GD3 ganglioside ratio.Lab Invest1992; 67: 711–5.
15.
GaspariniG.Anti angiogenic drugs as a novel anticancer therapeutic strategy.Which are the most promising agents? What are the clinical developments and indications? Crit Rev Oncol Hematol1997; 26: 147–62.
16.
O'ReallyM.S., BohemT., ShingY.Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.Cell1997; 88: 227–85.
17.
GordonM.S., TalpazM., MargolinK.Phase I trial of recombinant humanized monoclonal antivascular endothelial growth factor (anti VEGF MAB) in patients with metastatic cancer (abstract No. 809).Proc ASCO1998; 17: 210.
18.
StrawnL.M., ShawverL.K.Tyrosine kinases in diseases: overview of kinase inhibitors as therapeutic agents and current drugs in clinical trials.Exp Opin Invest Drugs1998; 7: 553–73.
